| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Molecular Medicine |
From the Departments of Clinical Cell Biology (F5) (Y.Z., K.O., S.H., T.K., M.S., K.T., Y.S.) and of Genome Research and Clinical Application (M6) (H.B., M.J.), Chiba University Graduate School of Medicine, Chiba, Japan; Kowa Research Institute (H.Y.), Kowa Co Ltd, Higashimurayama, Japan; Institute of Medical Biochemistry (S.H., W.J.S.), Department of Molecular Genetics, Biocenter and University of Vienna, Vienna, Austria.
Correspondence to Hideaki Bujo, Department of Genome Research and Clinical Application (M6), Chiba University Graduate School of Medicine,1-8-1 Inohana, Chuo-ku, Chiba 260-8670, Japan. E-mail hbujo{at}intmed02.m.chiba-u.ac.jp
LR11, a member of the LDL receptor family, is highly expressed in vascular smooth muscle cells (SMCs) of the hyperplastic intima, and induces enhanced migration of SMCs in vitro via its upregulation of urokinase-type plasminogen activator receptor (uPAR) expression. In this study, we have delineated the mechanism by which LR11 elevates the expression levels of uPAR in SMCs. Secretion of soluble LR11 is induced in SMCs during the rapidly proliferating phase, and the secreted LR11 induces the migration activities of SMCs. Both the cell-anchored and secreted forms of LR11 have the capacity to bind to and form complexes with uPAR. LR11-overexpressing cells show significantly enhanced uPAR binding, but decreased uPAR internalization. LR11 colocalizes with uPAR on the cell surface and inhibits the LDL receptorrelated protein (LRP)-mediated binding and internalization of uPAR. Thus, LR11 mediates the uPAR localization to the plasma membrane. LR11 is highly expressed in the atheromatous plaque areas of apoE knockout mice, particularly in the intimal SMCs at the border between intima and media. The neutralization of LR11 function with anti-LR11 antibody reduced cuff-induced intimal thickness in mice. The novel mechanism of regulation of uPAR localization in SMCs accompanied with enhanced migration activity possibly constitutes an important factor in the process of atherosclerosis and arterial remodeling.
Key Words: atherosclerosis smooth muscle cells receptors urokinase-type plasminogen activator receptor LDL receptorrelated protein
This article has been cited by other articles:
![]() |
S. S. Wang, W. Shi, X. Wang, L. Velky, S. Greenlee, M. T. Wang, T. A. Drake, and A. J. Lusis Mapping, Genetic Isolation, and Characterization of Genetic Loci That Determine Resistance to Atherosclerosis in C3H Mice Arterioscler. Thromb. Vasc. Biol., December 1, 2007; 27(12): 2671 - 2676. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. Nielsen, C. Gustafsen, P. Madsen, J. R. Nyengaard, G. Hermey, O. Bakke, M. Mari, P. Schu, R. Pohlmann, A. Dennes, et al. Sorting by the Cytoplasmic Domain of the Amyloid Precursor Protein Binding Receptor SorLA Mol. Cell. Biol., October 1, 2007; 27(19): 6842 - 6851. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Ohwaki, H. Bujo, M. Jiang, H. Yamazaki, W. J. Schneider, and Y. Saito A Secreted Soluble Form of LR11, Specifically Expressed in Intimal Smooth Muscle Cells, Accelerates Formation of Lipid-Laden Macrophages Arterioscler. Thromb. Vasc. Biol., May 1, 2007; 27(5): 1050 - 1056. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. J. Ting, J. P. Stice, U. Y. Schaff, D. Y. Hui, J. C. Rutledge, A. A. Knowlton, A. G. Passerini, and S. I. Simon Triglyceride-Rich Lipoproteins Prime Aortic Endothelium for an Enhanced Inflammatory Response to Tumor Necrosis Factor-{alpha} Circ. Res., February 16, 2007; 100(3): 381 - 390. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Bujo and Y. Saito Modulation of Smooth Muscle Cell Migration by Members of the Low-Density Lipoprotein Receptor Family Arterioscler. Thromb. Vasc. Biol., June 1, 2006; 26(6): 1246 - 1252. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Bohm, N. M. Seibel, B. Henkel, H. Steiner, C. Haass, and W. Hampe SorLA Signaling by Regulated Intramembrane Proteolysis J. Biol. Chem., May 26, 2006; 281(21): 14547 - 14553. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Yamaguchi, F. Matsumoto, H. Bujo, M. Shibasaki, K. Takahashi, S. Yoshimoto, M. Ichinose, and Y. Saito Revascularization Determines Volume Retention and Gene Expression by Fat Grafts in Mice Experimental Biology and Medicine, November 1, 2005; 230(10): 742 - 748. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Wang, X. Zhu, Q. Xu, X. Ding, Y. E. Chen, and Q. Song Effect of C-reactive protein on gene expression in vascular endothelial cells Am J Physiol Heart Circ Physiol, April 1, 2005; 288(4): H1539 - H1545. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. B. Westergaard, E. S. Sorensen, G. Hermey, M. S. Nielsen, A. Nykjaer, K. Kirkegaard, C. Jacobsen, J. Gliemann, P. Madsen, and C. M. Petersen Functional Organization of the Sortilin Vps10p Domain J. Biol. Chem., November 26, 2004; 279(48): 50221 - 50229. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Tanaga, H. Bujo, Y. Zhu, T. Kanaki, S. Hirayama, K. Takahashi, M. Inoue, K. Mikami, W. J. Schneider, and Y. Saito LRP1B Attenuates the Migration of Smooth Muscle Cells by Reducing Membrane Localization of Urokinase and PDGF Receptors Arterioscler. Thromb. Vasc. Biol., August 1, 2004; 24(8): 1422 - 1428. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2004 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |